Disruptive Pharma AB logo — Creating a pipeline of drug products based on our novel drug...

Disruptive Pharma AB

Creating a pipeline of drug products based on our novel drug delivery platform

Founded 2021 Sweden Sweden 17 employees Manufacturing, Pharmaceutical

General Information

Company Name Disruptive Pharma AB
Founded Year 2021
Location Sweden Sweden
Employees 17
Industries Manufacturing, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Disruptive Pharma AB. To contact Disruptive Pharma AB, visit disruptivepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Disruptive Pharma AB

Disruptive Pharma AB is a pharmaceutical startup with a focus on developing innovative drug products through a unique drug delivery technology. The company's proprietary drug delivery platform, pharma-grade mesoporous magnesium carbonate (Pharma-MMC), sets it apart in the industry. By leveraging this platform, Disruptive Pharma aims to create therapeutically equivalent or improved drug products using already approved active pharmaceutical ingredients (APIs). Furthermore, the technology enables the formation of amorphous solid dispersions, thereby enhancing drug dissolution and absorption—a crucial factor in the efficacy of pharmaceuticals. Based in Uppsala with a presence in Stockholm, the startup has a solid foundation, stemming from its origins as a spin-out from Disruptive Materials AB. The company's strategic position to capitalize on the pioneering discovery of MMC material gives it a competitive edge. Established in 2021, Disruptive Pharma operates within the manufacturing and pharmaceutical industries. With its innovative approach to drug development and the potential to revolutionize drug delivery, Disruptive Pharma presents a promising investment opportunity in the rapidly evolving pharmaceutical sector.

Taxonomy: novel drug delivery technology, pharmaceutical development, mesoporous magnesium carbonate, amorphous solid dispersions, therapeutic drug products, spin-out company, material science, drug formulation, API combination, drug absorption enhancement

No funding data available for Disruptive Pharma AB yet.

Disruptive Pharma AB Alternatives & Competitors

Disruptive Pharma AB vs
AustinPx
AustinPx United States

Client-Centric CDMO helping developers realize the full potential of their drug candidates.

Venture round
44 employees
Manufacturing, Pharmaceutical
Disruptive Pharma AB vs

Expressions for a Healthy Life

Post IPO
19366 employees
Health Care, Manufacturing
Disruptive Pharma AB vs
Delpharm
Delpharm France

A worldwide leader in contract development and manufacturing of medicines

Late Stage
3905 employees
Health Care, Manufacturing

FAQ About Disruptive Pharma AB

Creating a pipeline of drug products based on our novel drug delivery platform
Disruptive Pharma AB was founded in 2021.
Disruptive Pharma AB is headquartered in Sweden.
Disruptive Pharma AB operates in Manufacturing and Pharmaceutical. Its work centres on novel drug delivery technology, pharmaceutical development, mesoporous magnesium carbonate and amorphous solid dispersions.
Disruptive Pharma AB has approximately 17 employees.
Top alternatives and competitors to Disruptive Pharma AB include AustinPx, Intas Pharmaceuticals, Delpharm. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Disruptive Pharma AB and AustinPx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Disruptive Pharma AB, https://bouncewatch.com/company/disruptive-pharma-ab, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes